Azienda ULSS 8 Berica

Vicenza, Veneto 36100

0 studies enrolling now · 2 studies all time

What they study most

Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer, Non-small Cell Lung Cancer (NSCLC)

Studies at this site

• A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) — Completed
• A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer) — Running, not enrolling